The concept of “time in range” has been used in warfarin monitoring and glycemic management for diabetic patients, but why hasn't it caught on as a useful metric in controlling hypertension?

Cerner and Duke Clinical Research Institute have teamed up to develop a new CVD risk calculator app, the companies announced late this summer—a move they hope will improve shared decision-making between physicians and their patients.

Gregg W. Stone, MD, had the unenviable task of condensing the 255-page agenda for next weekend’s Transcatheter Cardiovascular Therapeutics (TCT) meeting into a handful of highlights during a 12-minute media briefing on Thursday, Sept. 13.

French pharmaceutical company Servier has partnered with Bioserenity to launch a “smart T-shirt” they’re calling the Cardioskin—a wearable innovation that would allow heart patients to monitor their cardiac rhythm throughout the day, the Daily Mail has reported.

Minimally invasive cardiac surgery without peripheral cannulation is both safe and effective for correcting a wide range of congenital heart defects, including mitral valve repair and pulmonary stenosis, according to research published in Heart, Lung and Circulation this week.

A record seven states had adult obesity rates exceeding 35 percent in 2017, according to new data released by the CDC.

Certain characteristics predict how responsive a blood clot will be to intravenous alteplase, according to research published Sept. 11 in JAMA—knowledge that may help clinicians more efficiently triage patients with acute ischemic stroke.

Research out of Australia suggests newborns with congenital heart disease (CHD) are likely to have enlarged kidneys at birth—a finding that could help alert physicians to organ abnormalities before a child is born.